Shifts from fee-for-service (FFS) to value-based reimbursement (VBR) models continue to transfer a significant percentage of clinical and financial risk from payers to providers.
Recent payment reforms promote movement from fee-for-service to alternative payment models that shift financial risk from payers to providers, incentivizing providers to manage patients' utilization.
It matters for your personal health, of course, but also in the calculation of what risk you represent within the pool of payers to your health insurer.
New payment and care organization approaches, such as those of accountable care organizations (ACOs), are reshaping accountability and shifting risk, as well as decision making, from payers to providers, within the Triple Aim context of health reform.
Understanding the economic burden of NEC in the long term would aid healthcare providers, policy makers and payers to make informed decisions in providing care for infants at high risk for NEC.
Therefore, it becomes important for payers to discuss with physicians the reasons for non-treatment among eligible high risk AF patients if a decline in anticoagulant prophylaxis in the population is observed over time.
Time, perhaps, for licence-fee payers to occupy.
His comments have emerged as a study predicted that one in 10 mortgage payers risk becoming trapped on unaffordable deals as interest rates rise over the next four years.
For instance, our model suggests that a pretravel consultation and malaria chemoprophylaxis (assuming, for example, use of doxycycline and 100% adherence) would result in net savings to healthcare payers when the risk of malaria at a destination exceeds 0.13 0.33 per 1000 person-days of travel.
This retrospective cohort study used longitudinal claims to calculate payer costs according to CHD risk level and type of CVE, during several follow-up periods (acute and short-term, comprising year 1; plus years 2 and 3).
